TuHURA BIOSCIENCES, INC./NV Total Shareholder Rtn Amt
TuHURA BIOSCIENCES, INC./NV (HURA) reported Total Shareholder Rtn Amt of $0.32 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-07-09.
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-07-09
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $0.32 DEF 14A · filed 2026-07-09 |
| 2024-12-31 | $0.46 DEF 14A · filed 2026-07-09 |
| 2023-12-31 | $3.82 DEF 14A · filed 2026-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |